← Open Payments lookup

JOVITA EZIRIM-SALAMIALOFOJE: Open Payments

NPI 1114320124 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$20,065 in 143 payments from 10 companies in 2025. Trend: 2023 $43,489 · 2024 $28,973 · 2025 $20,065

Speaker / faculty: $15,022Food & beverage: $4,241Travel & lodging: $401Consulting: $395Education: $7
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.41$16,615
Janssen Pharmaceuticals, Inc21$807
Alkermes, Inc.17$717
Otsuka America Pharmaceutical, Inc.22$558
E.R. Squibb & Sons, L.L.C.11$522
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$456
Neurocrine BioSciences, Inc.7$186
Luye Pharma (USA) Ltd.5$92
ABBVIE INC.5$92
Lundbeck LLC1$21

Products named: AUSTEDO XR, UZEDY, INVEGA SUSTENNA, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, LYBALVI.

Industry payments across CA — which companies pay providers there.